Association of a new mannose-binding lectin variant with severe malaria in Gabonese children

Genes and Immunity

Volumn 7, Issue 5, 2006, Pages 393-400

  Boldt, A B W ^a   Luty, A ^a,b   Grobusch, M P ^a,b   Dietz, K ^c   Dzeing, A ^d   Kombila, M ^c   Kremsner, P G ^a,b   Kun, J F J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ALBERT SCHWEITZER HOSPITAL   (Gabon)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d University of Libreville   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; MANNOSE BINDING LECTIN;

ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GABON; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCREENING;

ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CHEMOKINES; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOKINES; EVOLUTION, MOLECULAR; EXONS; GABON; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HAPLOTYPES; HUMANS; MALARIA; MANNOSE-BINDING LECTIN; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); SEVERITY OF ILLNESS INDEX; VARIATION (GENETICS);

EID: 33746337908     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364312     Document Type: Article

References (38)

1. World Health Organisation Communicable diseases cluster. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94: 1-94.
2. Rich SM, Licht MC, Hudson RR, Ayala FJ. Malaria's Eve: Evidence of a recent population bottleneck throughout the world populations of Plasmodium falciparum. Proc Natl Acad Sci USA 1998; 95: 4425-4430.
3. Ayi K, Turrini F, Piga A, Arese P. Enhanced phagocytosis of ring-parasitized mutant erythrocytes: A common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004; 104: 3364-3371.
4. Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA et al. Common west African HLA antigens are associated with protection from severe malaria. Nature 1991; 352: 595-600.
5. Mazier D, Nitcheu J, Idrissa-Boubou M. Cerebral malaria and immunogenetics. Parasite Immunol 2000; 22: 613-623.
6. Kun JFJ, Mordmüller B, Lell B, Lehman LG, Luckner D, Kremsner PG. Polymorphism in the promoter region of the inducible nitric oxide synthase gene and protection against malaria. Lancet 1998; 351: 265-266.
7. Koch O, Awomoyi A, Usen S, Jallow M, Richardson A, Hull J et al. IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J Infect Dis 2002; 185: 1684-1687.
8. Garred P, Nielsen MA, Kurtzhals JA, Malhotra R, Madsen HO, Goka BQ et al. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun 2003; 71: 5245-5253.
9. Luty AJF, Kun JFJ, Kremsner PG. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 1998; 178: 1221-1224.
10. Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003; 31: 753-757.
11. Klabunde J, Uhlemann AC, Tebo AE, Kimmel J, Schwarz RT, Kremsner PG et al. Recognition of Plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol Res 2002; 88: 113-117.
12. Jüliger S, Luckner D, Mordmüller B, May J, Weierich A, Lell B et al. Promoter variants of the human mannose-binding lectin gene show different binding. Biochem Biophys Res Commun 2000; 275: 617-622.
13. Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
14. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphisms of the mannose-binding lectin gene. Arthritis Rheum 1998; 41: 1663-1668.
15. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998; 161: 3169-3175.
16. Roos A, Garred P, Wildenberg ME, Lynch NJ, Munoz JR, Zuiverloon TC et al. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency. Eur J Immunol 2004; 34: 2589-2598.
17. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000; 241: 33-12.
18. Terai I, Kobayashi K, Matsushita M, Miyakawa H, Mafune N, Kikuta H. Relationship between gene polymorphisms of mannose-binding lectin (MBL) and two molecular forms of MBL. Eur J Immunol 2003; 33: 2755-2763.
19. Lee SG, Yum JS, Moon HM, Kim HJ, Yang YJ, Kim HL et al. Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol 2005; 42: 969-977.
20. Larsen F, Madsen HO, Sim RB, Koch C, Garred P. Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem 2004; 279: 21302-21311.
21. Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003; 37: 1496-1505.
22. Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002; 12: 335-352.
23. Mullighan CG, Marshall SE, Bunce M, Welsh KI. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun 1999; 1: 137-148.
24. Seibold F, Konrad A, Flogerzi B, Seibold-Schmid B, Arni S, Jüliger S et al. Genetic variants of the mannan-binding lectin are associated with immune reactivity to mannans in Crohn's disease. Gastroenterology 2004; 127: 1076-1084.
25. Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003; 188: 777-782.
26. de Miranda Santos IKF, Costa CH, Krieger H, Feitosa MF, Zurakowski D, Fardin B et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 2001; 69: 5212-5215.
27. Rector A, Lemey P, Laffut W, Keyaerts E, Struyf F, Wollants E et al. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease. Genes Immun 2001; 2: 323-328.
28. Schafranski MD, Stier A, Nisihara R, Messias-Reason IJ. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: A beneficial role for MBL deficiency. Clin Exp Immunol 2004; 138: 521-525.
29. Husby S, Herskind AM, Jensenius JC, Holmskov U. Heritability estimates for the constitutional levels of the collectins mannan-binding lectin and lung surfactant protein D. A study of unselected like-sexed mon- and dizygotic twins at the age of 6-9 years. Immunology 2002; 106: 389-394.
30. Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun 2004; 5: 461-476.
31. Luty AJ, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D et al. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect Immun 2000; 68: 3909-3915.
32. Bernig T, Breunis W, Brouwer N, Hutchinson A, Welch R, Roos D et al. An analysis of genetic variation across the MBL2 locus in Dutch Caucasians indicates that 3′ haplotypes could modify circulating levels of mannose-binding lectin. Hum Genet 2005; 118: 404-415.
33. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001; 184: 1152-1162.
34. Bellamy R, Ruwende C, McAdam KPWJ, Thursz M, Sumiya M, Summerfield J et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Q J Med 1998; 91: 13-18.
35. Kun JFJ, Schmidt-Ott R, Lehman LG, Lell B, Luckner D, Greve B et al. Merozoite surface antigen 1 and 2 genotyping and rosetting of Plasmodium falciparum in severe versus mild malaria in Lambaréné, Gabon. Trans R Soc Trop Med Hyg 1998; 92: 110-114.
36. Luckner D, Lell B, Greve B, Lehman LG, Schmidt-Ott RJ, Matousek P et al. No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. Trans R Soc Trop Med Hyg 1998; 92: 478-481.
37. Boldt AB, Petzl-Erler ML. A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 2002; 19: 296-306.
38. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 2000; 15: 7-12.